AKPro

Active Ingredient(s): Dipivefrin
FDA Approved: * September 29, 1995
Pharm Company: * AKORN
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



AKPro Overview

Dipivefrine (INN) or dipivefrin (USAN), trade name Propine among others, is a prodrug of epinephrine, and is used to treat open-angle glaucoma.[1][2] It is available[citation needed] as a 0.1% ophthalmic solution. It is no longer available in the United States.[3] Contents 1 Contraindications 2 Side effects 3 Pharmacology 4 References Contraindications Use in narrow-angle glaucoma may be dangerous because it could make t...

Read more AKPro Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dipivefrine

Recent AKPro Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dipivefrin
  • Solution: 0.1%
  • Solution/drops: 0.1%, 0.10%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Dipivefrin or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA